News & Media
Posters SITC 2022
Search on our website
Type Enter to start searching.
Scroll to explore
Latest press releases
Scroll back top
10 November 2022
Domain Therapeutics presents new data on its EP4R and CCR8 antagonists at 2022 SITC Annual Meeting
19 October 2022
Domain Therapeutics to progress into clinical trials with its EP4R antagonist DT-9081 in solid tumor...
6 October 2022
Domain Therapeutics to present new data on its EP4R and CCR8 antagonists at 2022 SITC Annual Meetin...
28 June 2022
Domain Therapeutics receives a single digit multimillion development milestone payment from Merck fo...
10 May 2022
Domain Therapeutics raises $42m Series A financing
19 April 2022
Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for GP...
10 March 2022
Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
27 January 2022
CONDOR project for precision medicine and sarcoma immunotherapy awarded close to €10m in the fifth...
8 April 2021
Domain Therapeutics presents most recent developments of its BRET technology portfolio at AACR and A...
8 December 2020
Domain Therapeutics launches Phase 1-enabling studies on proprietary EP4 receptor antagonist progra...
News & Media